Amritsar – Planet Herbs Lifesciences Pvt Ltd (PHL ), a venture of Sara Group of Industries launched it’s new product I- MOVE at Destination Punjab, 4-Day Expo organized by Confederation of Indian Industry (CII) at Ranjit Avenue, Amritsar. I-Move is a boon for people with joint pain as it normalizes cartilage metabolism, is useful in arthritis, rebuilds damaged cartilage and increases joint mobility. As important, the products is free from Heavy metals and pesticides and in compliance with internationally accepted GMP regulations.
According to Mr Ravi Kr. Berwar, Vice President, PHL, “Right from inception, the Comopany has been launching nutraceuticals and herbal based products with a focus on addressing the complications associated with modern sedentary life style. Our focus is on developing unique herbal formulae complementing the modern medicine range,” he added.
Registered with major countries like United States, Europe, Iraq, Sudan, Vietnam and Singapore, PHL is a contract manufacturer for companies like Ranbaxy Global Consumer Healthcare, Cipla Ltd., Panecea Biotech Ltd., and Ultra Biological Pvt. Ltd. Detailing his marketing plan, Mr Berwar said that the key players among Pharma Companies are GSK,Ranbaxy,Elder,ALkem and the new entries are Pletico,Mission Vivacare,GNC and Vitabiotics . FMCG companies in this segment include Nestle, Amul, Pepsico and Amway. We are pitching in both Pharma as well as FMCG segments with the focus on solutions of complications associated with modern lifestyle. We have a set of products being promoted through ethical promotion patronized by Doctors. For the OTC promotion, we have branded identified retailers as ‘Freedom points “, which will be promoted as one stop solution for all life style complications. The launch of I Move is first step in this direction.
“PHL is initially targeting Punjab. Similar launches are planned in near future at Delhi, Mumbai, Jaipur, Ahmedabad, Kolkata and Lucknow”, he further informed.
Talking about the current scenario, Mr Berwar said, “The Indian nutraceutical market is currently valued around at Rs 4500 crores and is expected to expand by Rs 9000 Crores by 2015. With healthy double digit 17-20% market growth rates, India is emerging as a global hub for contract research and manufacture of such nutraceutical herbal products, offering safe, effective, quality medicines at the best possible rates. The future is bright,” he asserted.
